Roche Romania

What Roche Romania does

Roche Romania (S.C. Roche Romania S.R.L.) is the Romanian subsidiary of Swiss-headquartered F. Hoffmann-La Roche Ltd, formally established as a local legal entity in 2005 after operating as a representative office since 1992. The company runs two integrated divisions — Pharmaceuticals and Diagnostics — under a single Bucharest headquarters in Ana Tower. The pharmaceutical division markets over 25 innovative medicines across oncology, hematology, neurology, ophthalmology, rare diseases, and infectious diseases, supported by a medical representative team that provides direct specialized support to over 500 physicians and 200+ hospitals, clinics, and laboratories nationwide. The diagnostics division offers in-vitro diagnostic tests, molecular diagnostic systems (cobas 5800, cobas pure), Point of Care instruments (cobas b 123 POC, CoaguChek XS), diabetes management solutions, and digital health platforms, distributed through authorized partners such as Bliss Concept DM SRL, Cominf SRL, Daiopharm Consulting SRL, and Farmacia Tei.

The company also operates Foundation Medicine genomic profiling services (FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne Heme) through authorized providers Laborator Regina Maria and Longevity Clinic in Bucharest, and runs patient-facing education platforms (canceruldesan.ro, cdelacontrol.ro) alongside the RochePlus physician portal. Revenue is generated through sale of innovative pharmaceutical products, diagnostic instruments, reagents and consumables, and professional genomic testing services. The business model combines direct enterprise field sales for pharmaceuticals (including a free Call Center at 0800-030 400 for patients to fill prescriptions) with a channel-partner and direct-distributor model for diagnostics.

Roche Romania's competitive positioning rests on the global Roche Group's R&D pipeline, its dual pharma-diagnostics structure enabling companion diagnostics and personalized medicine, regulatory certifications (ISO 9001:2015, GDPR data operator registration, EU-aligned pharmaceutical approvals), and a recently expanded footprint covering cardiovascular disease policy engagement, ophthalmology therapeutics (2025 intravitreal launch), and national oncology institute partnerships for multidisciplinary breast cancer care. Leadership is currently held by Director General Frank Loeffler, who also serves as Vice President of the Swiss-Romanian Chamber of Commerce.

Name

Roche Romania

Legal name

S.C. Roche Romania S.R.L.

Website

https://roche.ro

Company type

Private

Founded year

2005

Operating status

Operating

Short description

Roche Romania is the local subsidiary of F. Hoffmann-La Roche Ltd, operating integrated pharmaceutical and diagnostics divisions in Romania. It serves over 500 doctors and 200+ healthcare facilities with 25+ innovative medicines, IVD platforms, genomic tests, and digital health solutions across oncology, hematology, neurology, ophthalmology, and rare diseases.

Ownership category

akta.pro rank

Product category

Pharmaceuticals & Diagnostics

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541), Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Pharmaceutical Preparations (2834), In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Oncology Specialty Pharmaceuticals (HLAIACAA)

akta.pro secondary industries

Specialty Care Pharmaceuticals (HLAIAAAB), Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF), Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

Keywords

• Pharmaceutical products
• In-vitro diagnostics
• Molecular diagnostics
• Genomic profiling
• Oncology therapies

Headquarters

HQ city

Bucharest

HQ country

Romania

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Pharmaceutical Products: Roche Romania pharmaceutical division offers over 25 innovative products addressing oncology, hematology, neurology, ophthalmology, and rare diseases. Products are high-tech medicines distributed through medical representatives to healthcare professionals and hospitals.
2. Diagnostic Solutions: Roche Diagnostic Romania provides in-vitro diagnostic tests, instruments, and reagents for clinical laboratories, molecular diagnostics, anatomical pathology, blood banking, and Point of Care testing. Revenue generated through sale of instruments, reagents, and consumables.
3. Foundation Medicine Genomic Testing: Genomic profiling tests (FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne Heme) available through selected healthcare providers, providing comprehensive cancer genomic analysis for treatment decision support.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Core offering

Roche Romania sells innovative pharmaceutical products (over 25 medicines across oncology, hematology, neurology, ophthalmology, and rare diseases) and a diagnostics portfolio that includes in-vitro diagnostic tests, molecular and Point of Care instruments (cobas 5800, cobas pure integrated solutions, cobas b 123 POC, CoaguChek XS), reagents, FoundationOne genomic profiling tests, and digital health solutions. Customers include hospitals, clinical laboratories, physicians, and patients who access prescribed medicines via a free national Call Center.

Product overview

Roche Romania operates through two main divisions: Pharmaceuticals and Diagnostics. The pharmaceutical division offers over 25 innovative medicines for oncology, hematology, neurology, ophthalmology, and rare diseases, facilitated through the RochePlus physician portal. The diagnostic division provides in-vitro diagnostic tests, laboratory instruments (including cobas 5800, cobas pure integrated solutions, cobas b 123 POC, CoaguChek XS), and digital health solutions. Foundation Medicine genomic tests (FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne Heme) are available through partnered laboratories. Patient-facing platforms include Canceruldesan.ro and CdelaControl.ro for cancer education. The portfolio addresses therapeutic areas including hematology, neurology, oncology, ophthalmology, and infectious diseases.

Differentiator

Problem solved

Functional benefit

Brands

• Roche Diagnostics Romania: Diagnostics division of Roche Romania operating across all market segments from scientific research and laboratory systems to patient self-monitoring.
• Roche Pharmaceuticals Romania
• RochePlus

Products and services

• Pharmaceutical Portfolio Over 25 innovative pharmaceutical products prescribed by physicians and delivered to patients via the Roche Call Center, addressing oncology, hematology, neurology, ophthalmology, and rare diseases.
• In-vitro Diagnostic Tests Diagnostic tests for detecting pathologies, predispositions, and infections using biological samples (serum, whole blood, or tissue fragments), covering cancer, diabetes, COVID-19, hepatitis, HPV and other conditions, sold to clinical laboratories and hospitals.
• Diagnostic Instruments Laboratory diagnostic instruments ranging from small devices for physician offices to large automated analysis modules for central laboratories that process hundreds of samples in parallel.
• cobas 5800 Molecular Diagnostic System Molecular diagnostic system designed to expand access to molecular testing and improve patient care in laboratories.
• cobas pure integrated solutions Integrated analyzer designed to simplify operations in small and medium-sized laboratories.
• cobas b 123 POC system Point of Care diagnostic system for near-patient testing, distributed in Romania exclusively by Daiopharm Consulting SRL.
• CoaguChek XS Point of Care instrument for coagulation self-monitoring and professional near-patient testing.
• FoundationOne CDx Comprehensive genomic profiling test for solid tumors that delivers clinically actionable information to guide treatment decisions.
• FoundationOne Liquid CDx Blood-based comprehensive genomic profiling test for solid tumors using liquid biopsy methodology.
• FoundationOne Heme Comprehensive genomic profiling test for hematologic malignancies and sarcomas.
• Digital Health Solutions Evidence-based digital health solutions providing actionable insights for patient care, including workflow optimization for laboratories, virtual care for healthcare providers, and diagnostic digital solutions for patient self-monitoring.
• Roche Diabetes Care Personalized integrated diabetes management (iPDM) products and solutions for diabetes monitoring and management, building on more than 40 years of innovation.
• Laboratory Solutions Workflow and operations solutions for laboratory efficiency optimization covering clinical laboratory, molecular testing, anatomic pathology, and blood banking.
• Next-Generation Sequencing Solutions Sequencing solutions enabling deeper understanding of genetic mutations and inherited conditions for research applications.
• CustomBiotech High-quality raw materials, instruments, products and services for biopharmaceutical, cellular therapy, or in vitro diagnostic businesses with unique quality and regulatory needs.
• Intravitreal Ophthalmic Therapy for Retinal Diseases Innovative therapy administered via intravitreal injection for retinal diseases including neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion.

Quantifiable outcome

• 25,000 Romanians helped annually through community involvement projects
• +2 more outcomes

Named customers9 records

Segments7 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Swiss-Romanian Chamber of Commerce (CCE-R)coreStrategic or Co-development Partner · 1 January 2025Roche Romania, under Director General Frank Loeffler who serves as Vice President of the Swiss-Romanian Chamber of Commerce, collaborates on healthcare policy initiatives including the National Strategy for Cardiovascular Disease prevention, aligned with the European Cardiovascular Health Plan.
• Institutul Regional de Oncologie Iasi (IRO)coreStrategic or Co-development PartnerMajor oncology institute collaborating on breast cancer awareness events, promoting multidisciplinary team approaches for optimal breast cancer management according to international guidelines.
• Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj-Napoca (IOCN)coreStrategic or Co-development PartnerLeading oncology institute in Romania partnering for breast cancer awareness and treatment optimization through multidisciplinary team approaches.
• Institutul Oncologic Prof. Dr. Alexandru Trestioreanu Bucuresti (IOB)coreStrategic or Co-development PartnerMajor Bucharest oncology institute collaborating on breast cancer multidisciplinary care and treatment protocols.
• Romanian Patient AssociationscoreStrategic or Co-development PartnerPartnerships with patient associations for prevention campaigns, screening programs, and chronic disease awareness including breast cancer, colorectal cancer, cervical cancer, prostate cancer, multiple sclerosis, and hemophilia.
• Swiss Embassy in RomaniaminorStrategic or Co-development PartnerCo-organized debate on cardiovascular disease strategy with Swiss Ambassador Massimo Baggi, bringing together health ministry officials and international experts.
• Bliss Concept DM SRLminorChannel Partner/ Reseller/ DistributorAuthorized distributor for Point of Care diagnostic products including CoaguChek XS instruments.
• Daiopharm Consulting SRLminorChannel Partner/ Reseller/ DistributorExclusive distributor for cobas b 123 POC system for diagnostic testing.
• Prof. Effy Vayena, ETH ZurichminorStrategic or Co-development PartnerBioethics expert from Swiss Federal Institute of Technology Zurich contributing to healthcare data ethics discussions in Romania.
• Mark Bale, Council of EuropeminorStrategic or Co-development PartnerMember of Council of Europe Directorate for Human Rights in Biomedicine providing international perspective on health data governance.

Scale indicators8 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Pfizer Romania: One of the largest multinational innovators in Romania with overlapping oncology, hematology, and infectious disease portfolios. Competes head-to-head for hospital formulary inclusion and physician mindshare across the same 500+ HCP relationships.
• Abbott Romania: Closest diagnostics competitor, offering IVD analyzers, reagents, and point-of-care systems into the same Romanian hospital and reference lab channels. Directly competes with Roche's cobas installed base and Foundation Medicine territory.
• Sanofi Romania: Specialty pharma peer with overlapping franchises in rare diseases, oncology, neurology (multiple sclerosis), and immunology, using a comparable enterprise field-sales model across Romanian hospitals and clinics.
• Bayer Romania: Diversified pharma + consumer health peer with overlapping specialty franchises (ophthalmology, oncology, radiology contrast) and a comparable hospital-facing field sales model in Romania.
• Eli Lilly Romania: Innovator pharma peer with growing oncology, diabetes, and neurology portfolios in Romania, directly contesting specialty hospital channels and reimbursement positions.
• Novartis Romania: Direct competitor operating the same Swiss-pharma playbook in Romania, with parallel specialty pharma portfolios spanning oncology, neurology, hematology, and ophthalmology sold through hospital-channel field sales. Comparable in size, therapeutic breadth, and physician-relationship depth.
• Johnson & Johnson Innovative Medicine Romania: Pharmaceutical division of J&J operating in Romania with overlapping oncology, hematology, and pulmonary hypertension franchises, competing through the same hospital channel and clinical decision-maker relationships.
• Merck Romania (MSD): Direct peer with oncology, vaccines, and hospital specialty portfolios, comparable GTM motion using medical representatives, and similar engagement with Romania's leading oncology centers and reimbursement authorities.
• AstraZeneca Romania: Major oncology and specialty pharma competitor in Romania with a similarly strong hospital-focused field sales motion and pipeline overlap in breast/lung cancer and rare diseases. Directly contests the same oncology institute partnerships.
• AbbVie Romania: Specialty pharma peer focused on oncology, hematology, immunology, and neurology — competing directly for the same specialty-care physician relationships and hematology/oncology budgets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xtwitter.com/roche
• YouTubeyoutube.com/roche
• Facebookfacebook.com/roche
• LinkedInlinkedin.com/company/roche-romania
• Instagraminstagram.com/roche

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Roche Romania